Cristina Monterrubio-Lasarte
A Coruna, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Natural and synthetic chemicals acting as enhancers of bacterial pathogenic success within the human host.
Journal: Frontiers in cellular and infection microbiology
Published: April 21, 2026
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors.
Journal: Antimicrobial agents and chemotherapy
Published: January 10, 2025
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 16, 2024
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: April 12, 2024
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
Journal: The Journal of antimicrobial chemotherapy
Published: October 31, 2023
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1.
Journal: Antimicrobial agents and chemotherapy
Published: May 17, 2023
Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales.
Journal: Antibiotics (Basel, Switzerland)
Published: March 10, 2023
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.
Journal: International journal of antimicrobial agents
Published: December 02, 2022
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
Journal: The Journal of antimicrobial chemotherapy
Published: November 08, 2022
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain.
Journal: International journal of antimicrobial agents
Published: August 02, 2022
Reply to Shapiro, "Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing Enterobacterales".
Journal: Antimicrobial agents and chemotherapy
Published: April 26, 2022
Last Updated: 09/26/2026